Therese A. West, DNP, APN, BC Col (R) Stephen Sharp, MD CCSi contracting support for Defense and Veterans Brain Injury Center, The Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, Silver Spring, Md (Dr. West); Departments of Anesthesia and Neurology, Walter Reed National Military Medical Center, Bethesda, Md (Dr. Sharp) therese.a.west.ctr@mail.mil
The authors reported no potential conflict of interest relevant to this article.
The views, opinions, and/or findings contained in this article are those of the authors and should be construed as an official Department of Defense position, policy, or decision unless so designated by other official documentation.
The research areas given the highest priority by the group were incidence and prevalence studies of pituitary dysfunction after TBI in the combat military population, including pre- and postdeployment rates of dysfunction and the incidence of comorbidities. Also of benefit would be a retrospective study of the consequences of pituitary dysfunction that additionally addresses the effects of comorbid conditions commonly associated with TBI. Considering the rapid expansion in the field of mTBI, additional research and provider awareness concerning early identification and treatments may improve the outcomes for those with persistent mTBI symptoms.
CORRESPONDENCE Theres A. West, DNP, APN, BC, Defense and Veterans Brain Injury Center, 1335 East West Highway, 6th floor, Silver Spring, MD 20910; therese.a.west.ctr@mail.mil
